Detalles de la búsqueda
1.
The DNA methyltransferase inhibitor, guadecitabine, targets tumor-induced myelopoiesis and recovers T cell activity to slow tumor growth in combination with adoptive immunotherapy in a mouse model of breast cancer.
BMC Immunol;
21(1): 8, 2020 02 27.
Artículo
en Inglés
| MEDLINE | ID: mdl-32106810
Resultados
1 -
1
de 1
1
Próxima >
>>